



The companies’ research is being hailed by cancer specialists as a possible breakthrough because the resulting drugs could be used to treat many forms of the disease. Most cancer drugs on are effective against only certain types of cancer.



Merck, Roche and Sanofi are not yet testing their drugs in clinical trials against many kinds of cancer but Cellceutix, which was not mentioned in the Times article, said Monday it is already conducting such trials with a p53 drug called Kevetrin at the Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center in Boston.

Oh, but that's right, progressives: corporations aren't, so please don't use any of these innovations that will benefit all of humanity.The incessant class warfare waged by Obama and the Democrats is not only a tactic stolen straight from the Communist Manifesto, but it is also destructive of the civil society.Class warfarethe individual.But we are all. We are not segments, lumped together into random collections by income, race, gender or religion. We are, each with our own unique characteristics, strengths and weaknesses.Is the money that an investor could use to fund this cancer research better spent by government?That's what the Alinsky-trained Democrats would tell us. And they are wrong.